Besides, quality 3C5 irAEs except hematological toxicities had been almost comparable between ICI monotherapy and mixtures (all significantly less than 5%, Fig
Besides, quality 3C5 irAEs except hematological toxicities had been almost comparable between ICI monotherapy and mixtures (all significantly less than 5%, Fig.?3C). Open in another window Figure 3 Treatment-related adverse occasions and immune-related undesirable events between immune system checkpoint inhibitor monotherapy and combination: (A) any kind of grade; (B) quality 1C2; (C) quality 3C5. Assessment…